Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease

Since anti-tumor necrosis factor (TNF)-α agents (TNF-α inhibitors) induce both clinical response and remission in patients with moderate to severe inflammatory bowel disease (IBD), the use of anti-TNF therapies has fundamentally changed the approach to treatment for patients with IBD. Infliximab (IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Katsuyoshi, Hamada, Shunsuke, Shimizu, Mikiko, Nanki, Kosaku, Mizuno, Shinta, Kiyohara, Hiroki, Arai, Mari, Sugimoto, Shinya, Iwao, Yasushi, Ogata, Haruhiko, Hisamatsu, Tadakazu, Naganuma, Makoto, Kanai, Takanori, Mochizuki, Mayumi, Hashiguchi, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171861/
https://www.ncbi.nlm.nih.gov/pubmed/30286108
http://dx.doi.org/10.1371/journal.pone.0204632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171861/
https://www.ncbi.nlm.nih.gov/pubmed/30286108
http://dx.doi.org/10.1371/journal.pone.0204632

Ejemplares similares